A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Tor Biering‐Sørensen, Nino Emanuel Landler et al.|NEJM Evidence|2023Cited by 68
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trialNiklas Dyrby Johansen, Tor Biering‐Sørensen, Daniel Modin et al.|Clinical Microbiology and Infection|2024Cited by 23
Effects of <scp>high‐dose</scp> versus <scp>standard‐dose</scp> quadrivalent influenza vaccine among patients with diabetes: A <scp>post‐hoc</scp> analysis of the <scp>DANFLU</scp> ‐1 trialMats Christian Højbjerg Lassen, Tor Biering‐Sørensen, Niklas Dyrby Johansen et al.|Diabetes Obesity and Metabolism|2024Cited by 9
Author response for "Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial"Mats Christian Højbjerg Lassen, Tor Biering‐Sørensen, Lasse S. Vestergaard et al.|Unknown|2024Cited by 0